Hydroxyzine Orifarm (Hydroxyzine Hydrochloride)

Hydroxyzine works by selectively blocking peripheral H1 histamine receptors, which prevents histamine‑mediated vasodilation, increased vascular permeability and sensory nerve activation. Its additional anticholinergic activity reduces secretions, while central nervous system depression produces calming and sedative effects. This combined pharmacology alleviates allergy symptoms, itching, anxiety and nausea.

The appropriate dose of Hydroxyzine Orifarm is determined by the prescribing clinician based on the patient’s age, weight, medical condition and response to therapy. Dosage may vary for different indications such as allergy, pruritus or anxiety, and adjustments are made according to clinical judgment and tolerability. Patients should follow the exact instructions on the prescription label.

Safety data for hydroxyzine during pregnancy are limited, and the drug is classified as pregnancy category unknown. It should be used only if the potential benefit outweighs any possible risk to the fetus. While small amounts are excreted in breast milk, breastfeeding mothers should consult their healthcare provider before using the medication to assess any risk to the infant.

To place an order, visit the product page on gnhindia.com, enter the required quantity and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details (including any cold‑chain requirements) and assists with import documentation.

Compared with second‑generation antihistamines, hydroxyzine provides stronger sedative and anticholinergic effects, making it useful when calming or sleep‑inducing properties are desired. However, it is more likely to cause drowsiness and dry mouth than newer agents such as cetirizine or loratadine, which have reduced central nervous system penetration. Choice of therapy depends on the clinical need for sedation versus a preference for minimal daytime drowsiness.

Hydroxyzine Orifarm should be stored at temperatures below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date. No special refrigeration is required for this oral tablet, but it should be handled in a dry environment to maintain stability.

The medication is taken orally, usually with a glass of water. It may be taken with or without food, depending on the prescriber’s advice. Tablets should be swallowed whole and not crushed or chewed unless specifically instructed. Patients should follow the dosing schedule provided by their healthcare professional and avoid missing doses or taking extra tablets without guidance.

The most serious adverse reactions include cardiac arrhythmias, severe hypotension, hepatic dysfunction, and rare cases of anaphylaxis or neuroleptic malignant syndrome. Patients experiencing palpitations, fainting, yellowing of the skin or eyes, rash, swelling, or high fever should seek immediate medical attention. Monitoring is especially important in individuals with pre‑existing heart disease or liver impairment.

Hydroxyzine Orifarm is contraindicated in patients with known hypersensitivity to hydroxyzine or any component of the formulation. It should also be avoided in individuals taking monoamine oxidase inhibitors within 14 days, and in patients with severe hepatic impairment where metabolism is compromised. Caution is advised for the elderly, those with glaucoma, urinary retention, or severe constipation, and it should not be used in children unless specifically prescribed by a pediatric specialist.